Good-Ides

Official title: An Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in anti-GBM disease (Goodpasture’s disease) with Adverse Renal Prognosis --GOOD-IDESTrial start year: 2017

Trial website

No website available

Trial registration

NCT03157037
View registration

Design paper

No design paper published

Result paper

No result paper published